Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 2/20 | 0.39 |
| ▸ | JAK1 | P23458 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 6/20 | 0.38 |
| ▸ | SRC | P12931 | 6/20 | 0.38 |
| ▸ | EGFR | P00533 | 8/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | VCP | P55072 | 3/20 | 0.37 |
| ▸ | PSMC4 | P43686 | 1/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.37 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13759512 | 0.84 | CYP1A2 (0.31) | JAK3 | |
| SCHEMBL2623136 | 0.82 | BRAF (0.36) | — | |
| SCHEMBL19735835 | 0.82 | BRD4 (0.33) | — | |
| SCHEMBL21181331 | 0.80 | BTK (0.44) | JAK3JAK1FYNSRCEGFR | |
| SCHEMBL5437606 | 0.80 | MKNK1 (0.38) | EGFR | |
| SCHEMBL29654971 | 0.80 | BRD4 (0.40) | EGFR | |
| SCHEMBL22118770 | 0.80 | BRD4 (0.40) | EGFR | |
| SCHEMBL536914 | 0.79 | BRAF (0.47) | JAK3 | |
| SCHEMBL4905900 | 0.79 | ATG4B (0.39) | — | |
| SCHEMBL1398283 | 0.77 | BRD4 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | claimed |
| US-8263720-B1 | Sacrificial adhesive coatings | ROCHAL INDUSTRIES, LLP (US) | 2012-09-11 | — | — | US | claimed |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | ROCHAL TECHNOLOGIES LLC (US) | 2023-12-12 | — | — | US | disclosed |
| EP-1964893-B2 | Ink composition, inkjet recording method, printed material, and ink set | FUJIFILM CORP (JP) | 2021-11-24 | — | — | EP | disclosed |
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-2105478-B1 | Inkjet recording method and inkjet recording system | FUJIFILM CORP (JP) | 2018-02-28 | — | — | EP | disclosed |
| EP-1964893-B1 | Ink composition, inkjet recording method, printed material, and ink set | FUJIFILM CORP (JP) | 2018-01-24 | — | — | EP | disclosed |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | ROCHAL INDUSTRIES, LLC (US) | 2017-12-21 | — | — | US | disclosed |
| WO-2017218802-A1 | SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2017-12-21 | — | — | WO | disclosed |
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | disclosed |
| US-20160095876-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | CRG SERVICING LLC | 2016-04-07 | — | — | US | disclosed |
| EP-1964893-A1 | Ink composition, inkjet recording method, printed material, and ink set | FUJIFILM Corporation (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-20080206527-A1 | INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, AND INK SET | FUJIFILM CORPORATION (JP) | 2008-08-28 | — | — | US | disclosed |
| US-20080206527-A1 | INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, AND INK SET | FUJIFILM CORPORATION (JP) | 2008-08-28 | — | — | US | disclosed |
| US-20080075882-A1 | PROCESS FOR PRODUCING MOLDED PRINTED MATERIAL, AND MOLDED PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080075882-A1 | PROCESS FOR PRODUCING MOLDED PRINTED MATERIAL, AND MOLDED PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080075884-A1 | radiation curing ink cures with high sensitivity to form a high quality, durable image resistant to cracking, peeling and has excellent impact resistance, flexibility, and adhesion; a polymerizable monomer and a polymerization initiator and comprising substantially no colorant | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080075884-A1 | radiation curing ink cures with high sensitivity to form a high quality, durable image resistant to cracking, peeling and has excellent impact resistance, flexibility, and adhesion; a polymerizable monomer and a polymerization initiator and comprising substantially no colorant | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| WO-2007067866-A2 | CONFORMABLE BANDAGE AND COATING MATERIAL | ROCHAL INDUSTRIES, LLP (US) | 2007-06-14 | — | — | WO | disclosed |
| US-20070129474-A1 | Solution of an amphiphilic copolymer of a nitrogen-containing monomer, such as N-isopropylacrylamide, and a siloxy monomer, preferably 3-(methacryloyloxy)propyltris(trimethylsiloxy)silane in non-stinging, volatile, siloxane, alkane, fluorocarbon, lor iquid or supercritical carbon dioxide; medical devices | ROCHAL INDUSTRIES, LLP. (US) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160095876-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | CUTA, MMP8, MMP1 | JAK3 4695/4885JAK1 4455/4885FYN 2029/4885 |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | CUTA, MMP8, MMP1 | JAK3 4694/4885JAK1 4448/4885FYN 2042/4885 |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | CUTA, MMP8, MMP1 | JAK3 4694/4885JAK1 4448/4885FYN 2042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.